Cargando…
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
BACKGROUND: Glycopyrronium tosylate (GT) is a topical anticholinergic approved in the USA for primary axillary hyperhidrosis in patients aged ≥ 9 years. GT was evaluated for primary axillary hyperhidrosis in replicate, randomized, double-blind, vehicle-controlled, phase III trials. GT reduced sweati...
Autores principales: | Pariser, David M., Hebert, Adelaide A., Drew, Janice, Quiring, John, Gopalan, Ramanan, Glaser, Dee Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516143/ https://www.ncbi.nlm.nih.gov/pubmed/30378087 http://dx.doi.org/10.1007/s40257-018-0395-0 |
Ejemplares similares
-
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
por: Glaser, Dee Anna, et al.
Publicado: (2019) -
Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study
por: Hebert, Adelaide A., et al.
Publicado: (2020) -
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis
por: Pariser, David M., et al.
Publicado: (2021) -
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
por: Hebert, Adelaide A., et al.
Publicado: (2018) -
Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
por: Lamb, Yvette N.
Publicado: (2019)